AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Ondansetron Hydrochloride Equivalent To Ondansetron

22 registrations across 1 African market— 16 active

Markets with Ondansetron Hydrochloride Equivalent To Ondansetron

Recent registrations

Brand / ProductMarketHolderStatusExpires
ZANTRON-4🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
ZANTRON-8🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
VOMIZ INJECTION 8 mg/4 ml🇿🇦South AfricaZydus Healthcare (Pty) LtdsuspendedAug 2022
ONDANSETRON CIPLA IV 4 mg🇿🇦South AfricaZydus Healthcare (Pty) LtdsuspendedAug 2022
ONDANSETRON CIPLA IV 8 mg🇿🇦South AfricaZydus Healthcare (Pty) LtdsuspendedAug 2022
VOMIZ INJECTION 4 mg/2 ml🇿🇦South AfricaZydus Healthcare (Pty) LtdsuspendedAug 2022
ZOTHENA 8 mg🇿🇦South AfricaEurolab (Pty) LtdactiveJan 1900
ZOTHENA 4 mg🇿🇦South AfricaEurolab (Pty) LtdactiveJan 1900
ONDANSETRON HEXAL 4 mg BIOTECH🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
ONDANSETRON 8 mg BIOTECH🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
ONDANSETRON 4 mg/2 ML PHARM C🇿🇦South AfricaPharmacorp (Pty) LtdactiveJan 1900
VOMIZ 8🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
VOMIZ D 8 mg TABLETS🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
ONDANSETRON 4 mg BIOTECH🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
ONDANSETRON 8 BIOTECH🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
EMISTOP 4 mg🇿🇦South AfricaPharma Dynamics (Pty) LtdactiveJan 1900
ONDANSETRON 8 mg/4 ML PHARM C🇿🇦South AfricaPharmacorp (Pty) LtdactiveJan 1900
EMISTOP 8 mg🇿🇦South AfricaPharma Dynamics (Pty) LtdactiveJan 1900
ONDANSETRON CIPLA TABLETS 4🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
ONDANSETRON CIPLA TABLETS 8🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
VOMIZ 4🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
VOMIZ D 4 mg TABLETS🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900

Ondansetron Hydrochloride Equivalent To Ondansetron in Africa — Regulatory Overview

Ondansetron Hydrochloride Equivalent To Ondansetron is registered across 1 African markets with 22 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 22 registrations, 16 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.